Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2022 Latino Invisibility in the Pandemic Marina Del Rios, MD, Sylvia Puente, Pamela Vergara-Rodriguez, MD, and Noreen Sugrue Devastating effects of COVID-19 among Latinos have not been adequately emphasized by media, public health, research, or government. AMA J Ethics. 2022;24(4):E289-295. doi: 10.1001/amajethics.2022.289. Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296. Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711. Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487. Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514. Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Apr 2022 Latino Invisibility in the Pandemic Marina Del Rios, MD, Sylvia Puente, Pamela Vergara-Rodriguez, MD, and Noreen Sugrue Devastating effects of COVID-19 among Latinos have not been adequately emphasized by media, public health, research, or government. AMA J Ethics. 2022;24(4):E289-295. doi: 10.1001/amajethics.2022.289.
Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296.
Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711.
Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487.
Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603.